JESSICA HUTTON: Open Payments
NPI 1457721854 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$225 in 12 payments from 9 companies in 2025. Trend: 2023 $343 · 2024 $671 · 2025 $225
Food & beverage: $225
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $40 |
| ABBVIE INC. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Cipher Pharmaceuticals US LLC | 1 | $23 |
| Exact Sciences Corporation | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| ViiV Healthcare Company | 1 | $14 |
Products named: UBRELVY, AIRSUPRA, VAQTA, Natroba, Ozempic, Wegovy, Cologuard Collection Kit, SHINGRIX.
Industry payments across AZ — which companies pay providers there.
